Consent and compliance

Do employment drug tests detect kratom? What standard panels cover, kratom's 2026 federal status, and what employers may do

On this page
  1. What is kratom, and what is its legal status in 2026?
  2. Do standard workplace drug tests detect kratom?
  3. Can a DOT employer test for kratom?
  4. What does the ADA mean for kratom testing?
  5. What about state law?
  6. How should safety-sensitive employers handle kratom?
  7. Checklist before you test for kratom
  8. Questions people ask

Standard employment drug tests do not detect kratom. DOT tests cannot include it, the federal (HHS) workplace panel lists no kratom compound, and a non-DOT employer that wants to test for it has to ask its laboratory for a specific test for kratom's alkaloids, mitragynine and 7-hydroxymitragynine (7-OH). Kratom is not a federally controlled substance, although DEA moved in 2026 to temporarily schedule some kratom-derived compounds, so a kratom test is not clearly a "test for illegal drugs" under the ADA: test only after a conditional offer, for everyone in the job category, and check state law first, as of November 2026.

Which substances common panels cover is explained in 5-panel vs 10-panel drug tests; this page covers kratom only.

Not legal advice. This page summarizes FDA's and DEA's kratom pages, DEA's 2026 scheduling documents in the Federal Register, 49 CFR Part 40, HHS's 2026 panel notice, the ADA and EEOC guidance, checked as of November 2026. Federal and state kratom rules were changing during 2026; check the current status before relying on any date.

FDA's FDA and Kratom page describes kratom (Mitragyna speciosa) as a tropical tree native to Southeast Asia whose leaf products are sold online and in stores. Mitragynine is its primary alkaloid; 7-OH is a minor one, under 2 percent of the alkaloids in natural leaves, but with substantially greater mu-opioid receptor potency. FDA says there are no FDA-approved kratom drug products, that kratom is not lawfully marketed as a drug, a dietary supplement or a food additive, and it warns of liver toxicity, seizures and substance use disorder. Its federal status as of November 2026:

SubstanceFederal statusSource
Kratom (the plant and its leaf products)Not controlled under the Controlled Substances Act; DEA lists it as a Drug and Chemical of ConcernDEA kratom fact sheet
Mitragynine pseudoindoxyl, MGM-15, MGM-16Temporarily in Schedule I from August 26, 2026 until August 26, 2028, unless extended or replaced91 FR 54948
7-OH and mitragynine pseudoindoxyl above a thresholdDEA notice of intent (October 14, 2026) to place them temporarily in Schedule I when, alone or combined, they exceed 1 mg per gram (solids) or 1 mg per milliliter (liquids), or when the mass of mitragynine is less than 100 times theirs; the order was to be published on or after November 13, 202691 FR 65370

The October notice replaced a July 6, 2026 notice for 7-OH alone at a lower threshold, which DEA withdrew. As of November 15, 2026 we had not found the 7-OH temporary order itself in the Federal Register, so check its status. States set their own rules too: FDA says state health and law enforcement agencies are the best source on state kratom laws, and DEA's fact sheet notes state regulations or prohibitions may apply.

Do standard workplace drug tests detect kratom?

TestIncludes kratom?Source
DOT test (urine)No. Laboratories may test DOT specimens only for marijuana, cocaine, amphetamines, opioids and PCP, and nothing else49 CFR 40.82
Federal agency test (HHS)No kratom compound in the 2026 urine or oral fluid panel lists91 FR 12308
Company panel (5, 10 or more panels)Only if the laboratory adds a kratom test; panels are configured by the laboratory and employerPanel comparison
Specific kratom testOnly where the laboratory offers one; ask which compounds it targets, how positives are confirmed, and whether an MRO reviews themYour laboratory's documentation

Because kratom's alkaloids act on opioid receptors, candidates sometimes ask whether kratom causes an opioid positive. The federal panels define their opioid analytes by name (codeine, morphine, hydrocodone, hydromorphone, oxycodone, oxymorphone, 6-acetylmorphine, and fentanyl in the HHS panel), and none is a kratom compound; questions about a specific assay belong with the laboratory and the MRO.

Can a DOT employer test for kratom?

Not inside the DOT program. Beyond the five-class limit in 40.82, Part 40 forbids using the federal Custody and Control Form or a DOT specimen for a company test and requires DOT and non-DOT testing to stay separate (40.13). FMCSA's rule says it does not affect employers' own authority over drug and alcohol use, including testing (382.111), so a carrier that wanted kratom testing would need a separate company program, subject to the ADA and state law below. A company-authority result is never reported to the FMCSA Clearinghouse, which takes only DOT results. The full DOT rules are in DOT drug testing requirements.

What does the ADA mean for kratom testing?

  • The drug-test exemption covers illegal drugs. The ADA says a test to determine the illegal use of drugs is not a medical examination (42 U.S.C. 12114(d)), and defines illegal use of drugs as use of drugs whose possession or distribution is unlawful under the Controlled Substances Act (12111(6)). Kratom is not federally controlled, so a test for it may not fit that exemption.
  • Medical examinations wait until after the offer. The ADA allows medical examinations after a conditional offer if all entering employees in the category take them and results are kept confidential in separate medical files (12112(d)(3)). The EEOC takes the same view of alcohol tests: its preemployment guidance says tests of alcohol use are medical, with no statutory exemption. See pre-employment medical exams and the ADA.
  • The illegal-drug exclusion may not apply. The ADA's exclusion of current illegal drug users (12114(a)) rests on the same definition, so it may not reach kratom use; a decision based on a kratom result needs a job-related reason and counsel's review.
  • Watch the 7-OH order. Once DEA's temporary order is published, 7-OH and mitragynine pseudoindoxyl above the threshold become Schedule I substances, which may change this analysis for tests aimed at those compounds.
  • Do not ask about it in interviews. FDA notes that people use kratom to self-treat pain, anxiety, depression and opioid withdrawal, and the EEOC says pre-offer questions about lawful drug use that are likely to elicit information about a disability are impermissible.

What about state law?

State drug testing statutes often define which substances an employer may test for and the steps it must follow, so start with the state's page from drug testing laws in hiring. One state program is moving now: Tennessee's Bureau of Workers' Compensation filed a proposed rule to add "natural and synthetic derivatives of the alkaloid mitragynine or metabolite 7-hydroxymitragynine (Mitragyna speciosa, also known as Kratom)" to the drug-free workplace program's definition of drug, with a hearing on November 10, 2026. Details and status are on Tennessee drug testing laws. Other states regulate kratom sales or possession; check the state's own statute rather than a summary.

How should safety-sensitive employers handle kratom?

For many employers the practical answer is an impairment rule rather than a new test: a written policy that bars working while impaired by any substance, lawful or not, supervisors trained to document what they observe, and a fitness-for-duty process that does not depend on a panel. Employers outside DOT that test safety-sensitive staff should read non-DOT drug testing for safety-sensitive jobs for the state limits on designating those jobs. If you do add a kratom test, put it in the written policy before testing anyone, apply it to every employee in the covered job category after the offer, and send results through an MRO.

A policy line to adapt (an example, to review with counsel):

Example:
Employees may not perform safety-sensitive work while impaired by
any substance, including alcohol, prescription or over-the-counter
medication, cannabis or hemp products, and kratom or kratom-derived
products. [If tested: For [job category], post-offer testing
includes kratom alkaloids, applied to all entering employees in
the category; results are reviewed by a Medical Review Officer and
kept in confidential medical files.]

Checklist before you test for kratom

  1. Decide why: tie any kratom test to safety-sensitive duties, not general screening.
  2. Confirm the job is not covered only by a DOT program; DOT specimens cannot be used.
  3. Check the state drug testing statute and any state kratom law where the person will work.
  4. Get the laboratory's documentation: compounds tested, cutoffs, confirmation method and MRO review.
  5. Put it in the written policy and test only after a conditional offer, for everyone in the job category.
  6. Keep results in confidential medical files, and track DEA's 7-OH order and any state rule changes.

Questions people ask

Does a 10-panel drug test detect kratom?

Not unless the laboratory adds a specific test for kratom's alkaloids, such as mitragynine or 7-hydroxymitragynine. Kratom is not part of the DOT panel or the HHS federal workplace panel, and non-DOT panels are configured by the laboratory and employer, so ask your laboratory what a given panel includes, as of November 2026.

Is kratom legal under federal law in 2026?

Kratom itself is not controlled under the Controlled Substances Act, according to DEA's kratom fact sheet, though FDA says it is not lawfully marketed as a drug, dietary supplement or food additive. In 2026 DEA temporarily placed mitragynine pseudoindoxyl in Schedule I (August 26, 2026) and announced on October 14, 2026 that it will temporarily schedule 7-hydroxymitragynine and mitragynine pseudoindoxyl above a concentration threshold.

Can a DOT employer test truck drivers for kratom?

Not as part of a DOT test. Laboratories may test DOT specimens only for marijuana, cocaine, amphetamines, opioids and phencyclidine (49 CFR 40.82). Any kratom testing would have to be a separate company test under the employer's own authority, with its own specimen and forms, kept apart from the DOT program (49 CFR 40.13), and subject to state law.

Can an employer test job applicants for kratom before making an offer?

It is risky. The ADA exempts only tests for the illegal use of drugs, meaning drugs unlawful under the Controlled Substances Act, from its rules on medical examinations (42 U.S.C. 12114(d) and 12111(6)). Because kratom is not federally controlled, a kratom test may be treated as a medical examination, which the ADA allows only after a conditional offer and only if all entering employees in the job category take it. Ask counsel first.

Does Tennessee require kratom testing in its drug-free workplace program?

Not yet, as far as the published proposal shows. Tennessee's Bureau of Workers' Compensation proposed in September 2026 to add mitragynine and 7-hydroxymitragynine to the program's definition of drug, with a rulemaking hearing on November 10, 2026. Check whether the rule has been adopted and when it takes effect before changing a program panel.